维普期刊资源整合服务平台（V6.5）

112篇 您的检索式：作者名="Albitar M"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Mammalian target of rapamycin as a therapeutic target in leukemia显示文摘	GILES F J ALBITAR M	2005	Curr Mol Med2005，5，7：	1
2	Efficacy of the famesyl transferase inhibitor R115777 in chronic rnyeloid leukemia and other hematologic malignancies显示文摘	Cortes J Albitar M Thomas D	2003	Blood2003，101，：	1
3	Efficacy of thefamesyl transferase inhibitor R115777 in chronic myeloid leukemiaand other hematologic malignancies 显示文摘	CORTfiS J ALBITAR M THOMAS D	2003	Blood2003，101，5：	1
4	Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome 显示文摘	Meyers CA Albitar M Estey E	2005	Cancer2005，104，4：	1
5	CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia,but CD38 expression is not显示文摘	Ishibe N Albitar M Jilani IB		0，，：	1
6	EGFR isoforms and gene regation in human endometrial cancer cells显示文摘	Albitar L Pickett G Morgan M		0，，：	1
7	A phase Ⅱ study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome显示文摘	Kurzrock R Albitar M Cortes JE	2004	J Clin Oncol2004，22，：	1
8	The use of the antibodies in the diagnosis of leukemia and lymphoma by flow cytometry显示文摘	Sheikholeslami MR Jilani I Albitar M	2007	Methods Mul Biol2007，378，：	1
9	After chemotherapy:clinical significance and therapeutic implications显示文摘	Carew JS Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
10	Chronic myelogenous leukaemia with p185 (BCR/ABL) expression: characteristics and clinical significance 显示文摘	Ravandi F Cortes J Albitar M	1999	Br J Haematol1999，107，3：	1
11	Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease显示文摘	Albitar M Vose JM Johnson MM		0，，02：	1
12	Levels of soluble HLA-I and beta-M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome:association with clinical behavior and outcome of induction therapy显示文摘	Johnson M Do KA	2007	Leukemia2007，11，：	1
13	Mitochondrial DNA mu tations in primary leukemia cells after chemotherapy:clinical significance and therapeutic implications显示文摘	Carew J S Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
14	Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration显示文摘	Smiler D Soltan M Albitar M	2008	Implant Dent2008，17，3：	1
15	Mitochondrial DNA mutations in primary leukemia cells after chemotherapy:clinical significance and therapeutic implications显示文摘	Carew J S Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
16	Intrinsic oxidative stress in cancer cells:a biochemical basis for therapeutic selectivity显示文摘	Hileman EO Liu J Albitar M et a1	2004	Cancer Chemother Pharmacol2004，53，3：	1
17	Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications 显示文摘	Carew JS Zhou Y Albitar M	2003	Leukemia2003，17，8：	1
18	Combined fludarabine, cyclophosphamide,and rituximab achieves a high complete remission rate as initial treatment for chronic lymphocytic leukaemia显示文摘	Widrda W O'Brien S Albitar M	2001	Blood2001，98，1：	1
19	Early results of a chemoimmunotherapy regimen of fludarabine,cyclophosphamide,and rituximab as initial therapy for chronic lymphocytic leukesmia显示文摘	Keating MJ O Brien S Albitar M		0，，：	1
20	Simplified reverse dot blot analyses for detecting of ras oncogene mutations 显示文摘	Albitar M Wu W I Feltz E	1997	Mol Diagn1997，2，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示